Salesforce stock ends eight-day skid; CRM investors scan AI signals after rough week
22 January 2026
1 min read

Salesforce stock ends eight-day skid; CRM investors scan AI signals after rough week

NEW YORK, Jan 21, 2026, 18:03 EST — After-hours trading

  • After slipping for eight sessions in a row, Salesforce bounced back, closing up 0.7% on Wednesday
  • The company has extended its startup program to Malaysia and the Philippines
  • Investor sentiment around software stays fragile amid ongoing debates over AI’s impact on pricing power

Salesforce shares edged up 0.7%, finishing Wednesday at $221.58. Oracle dropped 3.4%, and ServiceNow slipped 0.1%. The S&P 500 gained 1.2%. 1

The uptick came after CRM endured eight consecutive sessions of losses, including a 3.1% fall on Tuesday. That decline pushed the stock roughly 40% off its 52-week peak, with trading volume exceeding its recent average. 2

Salesforce expanded its Startup Program on Tuesday to include Malaysia and the Philippines, providing startups with access to its products, mentorship, and joint go-to-market support. “Malaysia and the Philippines are ideal launchpads for startups seeking to scale local ideas into global impact,” said Arundhati Bhattacharya, Salesforce’s president and CEO for South and Southeast Asia. The program now covers five markets and supports over 435 startups. 3

The broader software sector faces a tricky dilemma: will generative AI boost spending, or will easier-to-replicate tools drive prices down? Jefferies analyst Brent Thill noted this week that “software sentiment has rarely been lower.” At the same time, Banor SIM portfolio manager Angelo Meda cautioned that AI might weigh on the average selling price of software services. 4

At Davos, Salesforce CEO Marc Benioff posed a stark question: “What’s more important to us, growth or our kids?” 5

Salesforce investors are now focused on the upcoming quarterly earnings report and the guidance that will come with it. Back in December, the company upped its fiscal 2026 revenue and profit outlook, citing robust demand for AI offerings like Agentforce. Its data-and-AI segment was also flagged as expanding rapidly. 6

Traders are focused on subscription growth and the “remaining performance obligation,” which tracks contracted revenue still to be recognized. They want to see if customers are locking in larger deals or merely sampling AI features in limited trials.

The downside risk remains on the table. Should customers hold off on renewals, cut back on seat counts, or postpone AI pilots, backlog growth could stall quickly—and the stock’s recent rebound might vanish in a single session.

Investors are gearing up for a packed earnings slate in the sector, kicking off with Microsoft’s report on Jan. 28. Its results often set the tone for other major software stocks ahead of Salesforce’s next update. 7

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
GE Vernova stock drops 2.5% after Power CEO exit disclosure, with earnings next week
Previous Story

GE Vernova stock drops 2.5% after Power CEO exit disclosure, with earnings next week

Oklo stock swings late as Bank of America upgrades OKLO on Meta nuclear campus deal
Next Story

Oklo stock swings late as Bank of America upgrades OKLO on Meta nuclear campus deal

Go toTop